SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,175
Boards Moderated 0
Alias Born 02/13/10
160x600 placeholder
Advertisement
Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance "Business Wire" - 7/30/2015 7:30:00 AM
Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept™ in Rheumatoid Arthritis "Business Wire" - 7/29/2015 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/28/2015 4:25:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/28/2015 11:21:43 AM
Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant "Business Wire" - 7/28/2015 7:30:00 AM
Verification of Lymphoseek® Mechanism of Action Published in Journal of Immunology "Business Wire" - 7/23/2015 8:50:00 AM
Navidea Biopharmaceuticals to Announce Second Quarter 2015 Financial Results on July 30, 2015 "Business Wire" - 7/22/2015 3:56:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2015 4:29:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/21/2015 1:30:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/21/2015 1:28:21 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/20/2015 2:12:48 PM
Navidea Biopharmaceuticals Announces 2015 Annual Meeting Results "Business Wire" - 7/16/2015 5:16:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/8/2015 4:18:19 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 7/7/2015 5:02:16 PM
Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast / Call "Business Wire" - 7/7/2015 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 7/6/2015 4:12:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/6/2015 12:27:50 PM
Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast "Business Wire" - 7/2/2015 6:12:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/2/2015 4:08:09 PM
Macrophage Therapeutics Reports Data Demonstrating a Manocept™ Drug Conjugate Induces Apoptosis in CD206 Positive Kaposi’... "Business Wire" - 7/2/2015 7:45:00 AM
Navidea Reports Clinical Data Demonstrating Manocept™ Agent Localizes in Multiple KS Lesions "Business Wire" - 7/2/2015 7:30:00 AM
3 Biotech Stocks with Low Liquidity Ratios -- Are They in Trouble? "The Motley Fool" - 6/29/2015 9:03:02 AM
Navidea Biopharmaceuticals to Present at JMP Life Sciences Conference "Business Wire" - 6/17/2015 9:11:00 AM
Macrophage Therapeutics to Present at BIO2015 Conference "Business Wire" - 6/15/2015 7:30:00 AM
BIND Therapeutics & Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin™ Nanoparticle Using M... "Business Wire" - 6/11/2015 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist